Novartis India to acquire Pfizer's ‘Minipress’ trademark for ₹1,250 crore
IndiaWhat to know
- The deal includes trademarks registered in India and related intellectual property rights, with Minipress XL generating ₹228.6 crore revenue in the year ended July 2026.S1
- Mumbai: Novartis India’s board has approved the acquisition of the Minipress and Minipres trademarks registered in India from Pfizer Inc and Pfizer Products Inc for Rs 1,250 crore.The deal also covers certain intellectual property rights linked to the brands,...S2
Timeline · newest first
1mo
Thehindubusinessline
Novartis India to acquire Pfizer's ‘Minipress’ trademark for ₹1,250 crore
The deal includes trademarks registered in India and related intellectual property rights, with Minipress XL generating ₹228.6 crore revenue in the year ended July 2026.
1mo
Freepressjournal
Novartis India Buys Minipress Brand For ₹1,250 Crore, Pfizer To Stop Selling Hypertension Drug
Mumbai: Novartis India’s board has approved the acquisition of the Minipress and Minipres trademarks registered in India from Pfizer Inc and Pfizer Products Inc for Rs 1,250 crore.…
Related stories
IndiaDeveloping
India's GST Collections Reach Record High in October 2026
3 outlets
7h
India
India · Business & Economy
Foreign Portfolio Investors Withdraw ₹34,843 Crore from Indian Equities in October
2 outlets
9h
India
India · Business & Economy
Strong Financial Performance for Acme Universal Safezone and NTPC in Recent Quarters
2 outlets
1d
India
India · Business & Economy
Stoke Therapeutics, Inc. (STOK) Q3 2026 Earnings Call Transcript
2 outlets
2d
Other developing stories in India
Developing
Rishabh Pant's Injury Raises Concerns Ahead of New Zealand Series
4 outlets · 2h
New ZealandDeveloping
New Zealand Claims Final T20I Against India, Series Ends 3-2
3 outlets · 4h
New ZealandDeveloping
India Makes T20I History with 400 Sixes in a Year
3 outlets · 4h
IndiaDeveloping
Opposition Protests Intensify Against India's Elections Chief
3 outlets · 6h
India
2 outlets
2 reports
Published Sep 7, 2026
What to know
- The deal includes trademarks registered in India and related intellectual property rights, with Minipress XL generating ₹228.6 crore revenue in the year ended July 2026.S1
- Mumbai: Novartis India’s board has approved the acquisition of the Minipress and Minipres trademarks registered in India from Pfizer Inc and Pfizer Products Inc for Rs 1,250 crore.The deal also covers certain intellectual property rights linked to the brands,...S2
Timeline · newest first
Sources · 2 citations
S1
Thehindubusinessline
1 report · EN
S2
FreepressjournalLead
1 report · EN
Related stories
IndiaDeveloping
India's GST Collections Reach Record High in October 2026
3 outlets
7h
India
India · Business & Economy
Foreign Portfolio Investors Withdraw ₹34,843 Crore from Indian Equities in October
2 outlets
9h
India
India · Business & Economy
Strong Financial Performance for Acme Universal Safezone and NTPC in Recent Quarters
2 outlets
1d
India
India · Business & Economy
Stoke Therapeutics, Inc. (STOK) Q3 2026 Earnings Call Transcript
2 outlets
2d
Other developing stories in India
Developing
Rishabh Pant's Injury Raises Concerns Ahead of New Zealand Series
4 outlets · 2h
New ZealandDeveloping
New Zealand Claims Final T20I Against India, Series Ends 3-2
3 outlets · 4h
New ZealandDeveloping
India Makes T20I History with 400 Sixes in a Year
3 outlets · 4h
IndiaDeveloping
Opposition Protests Intensify Against India's Elections Chief
3 outlets · 6h
India